Skip to content
← Index board

Health Optimization Index

C60 (Buckminsterfullerene)

Nick’s assessment
Experimental
Research evidence
E, thin evidence
Attention
12.5 / 100▲ Rising this week
3/ 10

BioHarmony score

C60 in olive oil scores 3.0–3.5/10 because the famous Baati 2012 rat lifespan signal has not translated to humans and failed clean mammalian replication versus water controls in Shytikov 2021.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

C60 (Buckminsterfullerene) shows modest antioxidant activity but the evidence does not support oral longevity claims for most users. The only reproducible human data come from a small cosmetic trial that found modest wrinkle reduction after topical application Kato et al. 2010, which does not translate to systemic benefits. Rodent studies that reported dramatic lifespan extension were limited to a single rat experiment and later corrected for figure errors Baati et al. 2012 and a subsequent corrigendum, while independent mouse work found no advantage over water controls and suggested possible harm when delivered in olive oil Shytikov et al. 2021. Accordingly, C60 (Buckminsterfullerene) may be of interest to highly controlled self-experiments focused on short-term recovery, but it carries uncertain efficacy and safety for broader longevity or performance use in general.

✅ Best for: High-stress endurance athletes, ultra-marathoners, and advanced self-experimenters who already have the basics handled, can afford therapeutic-grade C60 oil, can verify storage and quality controls, and accept that the human evidence base is functionally absent for oral longevity. The strongest fit is someone testing a short, measurable recovery block during unusually high training stress, with clear stop criteria and no fertility, pregnancy, medication, or cancer-treatment concerns.

❌ Avoid if: You are pregnant, planning pregnancy, breastfeeding, trying to conceive, pediatric, taking photosensitizing drugs, using anticancer therapy, using anticoagulants without clinician review, or unable to refrigerate and store C60 away from light. Avoid C60 if you want evidence-validated longevity interventions, are on a tight supplement budget, or would be using it before proven basics. The audit found no large human RCT, no meta-analysis, no Cochrane review, and no positive FDA efficacy signal for consumer health claims.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on C60 (Buckminsterfullerene)
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.